Clinical trial
Endothelial Hyperpolarization in Humans
NCT00166166 · Emory University, Other · Terminated
Key facts
| NCT number | NCT00166166 |
|---|---|
| Title | Endothelial Hyperpolarization in Humans |
| Official title | Physiology and Pathologic Role of Endothelium-Derived Hyperpolarizing Factor in Humans |
| Lead sponsor | Emory University, Other |
| Collaborators | National Heart, Lung, and Blood Institute (NHLBI) NIH |
| Status | Terminated |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Hyperlipidemia |
| Intervention type | Drug |
| Interventions | Tetraethylammonium (TEA), L-NG-monomethyl Arginine (L-NMMA), Bradykinin, Sodium nitroprusside, Acetylcholine, Saline, Fluconazole |
| Enrollment | 174 |
| Start date | Jul 1, 2002 |
| Primary completion | Jan 1, 2013 |
| Completion | Jan 1, 2013 |
| First posted | Sep 14, 2005 |
| Last update posted | Aug 15, 2018 |
| Countries | United States |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: